Introduction: The overarching goal of the National Cancer Institute is to eliminate death and suffering from all cancers in the next 15 years. Longitudinal analyses of population-based cancer registries allow for meaningful comparisons of epidemiology and survival-related outcomes. In order to assess the quality of US cancer care, this study uses 2 complimentary population-based datasets to report the epidemiology and outcomes of nine surgery-related cancers over the past 3 decades. Methods: Using the SEER cancer database (1973–1999), all patients (>18 y/o) diagnosed with adenocarcinoma of esophagus, stomach, biliary duct, pancreas, small bowel, colon, rectum; esophageal squamous cell carcinoma (ESC), and hepatocellular (HCC) carcinoma (n = 382,032) were analyzed. Changes in incidence rates, stage at presentation (local, regional, distant), and 5-year cancer and stage-specific survivals were determined. The OSHPD database (1990–2000), which reports California inpatient discharges, was concurrently used to evaluate inpatient mortality after surgical resection for each cancer (n = 34,057). Results: Incidence rates increased for 3 cancers (esophageal, HCC, small bowel); decreased for 3 (rectal, stomach, ESC); and stayed constant for 3 (biliary, pancreatic, colon). More patients presented with local/regional disease in the 1990s (compared to 1970s) for 8 tumors (except small bowel, p < 0.05). Five-year overall survival improved for all but small bowel (p < 0.05); and survival for local stage tumors was improved for all cancer types except small bowel and biliary (p < 0.05). Finally, inpatient mortality rates, which can be a proxy for surgical quality and safety, declined significantly for liver, esophageal, pancreatic, and gastric resections (p < 0.05) over the past decade. Conclusions: This report card evaluates longitudinal trends in epidemiology and outcomes for 9 surgery-related cancers and identifies where improvements have been made. Not only does it appear that we are detecting tumors at an earlier and more treatable stage, but also that therapies have become more effective and safe over the past 3 decades. While these findings are encouraging, it highlights the importance of examining longitudinal trends for evaluating outcomes and areas for further study. [Copyright &y& Elsevier]